BRIEF published on 05/08/2024 at 13:05, 2 years ago Reaume Richardson annonce une transition de leadership pour stimuler la croissance future Changement De Direction Croissance De L'entreprise L'excellence Opérationnelle Industrie De Construction Relation Client
BRIEF published on 05/08/2024 at 13:05, 2 years ago Yunu Introduces Advanced Imaging Workflow for Investigator-Initiated Trials Data Management Yunu Clinical Trial Imaging Cloud-based Platform Investigator-initiated Trials
BRIEF published on 05/08/2024 at 13:05, 2 years ago Yunu présente un flux de travail d'imagerie avancé pour les essais lancés par les enquêteurs Yunu Gestion De Données Plateforme Basée Sur Le Cloud Imagerie Pour Essais Cliniques Essais Initiés Par Des Chercheurs
BRIEF published on 05/08/2024 at 12:55, 2 years ago TotalEnergies Announces First Oil Production at Eldfisk North in Norway Oil Production Norway TotalEnergies Eldfisk North North Sea
BRIEF published on 05/08/2024 at 12:55, 2 years ago TotalEnergies annonce la première production pétrolière à Eldfisk North en Norvège Norvège TotalEnergies Eldfisk Nord Production D'huile La Mer Du Nord
BRIEF published on 05/08/2024 at 12:35, 2 years ago Immunic, Inc. Announces Q1 2024 Financial Results and Corporate Updates Financial Strategy Immunic Inc Q1 2024 Financial Report Multiple Sclerosis Trials Celiac Disease Treatment
BRIEF published on 05/08/2024 at 12:35, 2 years ago Immunic, Inc. annonce ses résultats financiers du premier trimestre 2024 et des mises à jour sur l'entreprise Stratégie Financière Immunic Inc Rapport Financier Du Premier Trimestre 2024 Essais Sur La Sclérose En Plaques Traitement De La Maladie Coeliaque
BRIEF published on 05/08/2024 at 12:35, 2 years ago Résultats Positifs pour l'Essai Phase 3 SOLARIS sur l’Olanzapine Schizophrénie Medincell TEV-‘749 SOLARIS Olanzapine
BRIEF published on 05/08/2024 at 12:35, 2 years ago Positive Results for the SOLARIS Phase 3 Trial of Olanzapine Schizophrenia Medincell SOLARIS Olanzapine TEV-'749
BRIEF published on 05/08/2024 at 12:35, 2 years ago NanoViricides Announces Promising Results with NV-387 in Potentially Treating Smallpox and Mpox NanoViricides NV-387 Tecovirimat Smallpox Mpox
Published on 05/27/2026 at 23:42, 53 minutes ago New Horizon Aircraft Ltd. Announces Closing of $25 Million Offering of Common Shares
Published on 05/27/2026 at 23:05, 1 hour 30 minutes ago Vox Royalty Announces Annual and Special Meeting Results
Published on 05/27/2026 at 23:05, 1 hour 30 minutes ago Avino Reports Voting Results of Its 2026 Annual General Meeting
Published on 05/27/2026 at 23:00, 1 hour 35 minutes ago Collingwood Adopts Semi-Annual Financial Reporting Framework
Published on 05/27/2026 at 23:00, 1 hour 35 minutes ago Green Bridge Metals Reports Initial Assays from Drill Program
Published on 05/27/2026 at 23:29, 1 hour 5 minutes ago Market entry in Brazil: DEUTZ expands its energy business in Latin America
Published on 05/27/2026 at 23:09, 1 hour 25 minutes ago EQS-Adhoc: DEUTZ AG acquires Brazilian generator manufacturer Maxi Trust Power Ltda.
Published on 05/27/2026 at 20:52, 3 hours 42 minutes ago EQS-Adhoc: REPLOID Group AG: Procedural deficiencies related to the appointment of auditors in prior periods require remediation. Publication of the 2025 Annual Statements delayed.
Published on 05/27/2026 at 20:32, 4 hours 3 minutes ago Sirma Group Holding AD reports strong profitability growth in Q1 2026
Published on 05/27/2026 at 19:55, 4 hours 40 minutes ago IGEL Brings Now & Next Workspace & Endpoint Security Summits to Five European Cities
Published on 05/27/2026 at 23:00, 1 hour 35 minutes ago BIOPHYTIS MODIFIE SA LIGNE DE FINANCEMENT AVEC HEXAGON CAPITAL FUND POUR RENDRE RENOUVELABLE SA CAPACITE DE TIRAGE DE 2M€
Published on 05/27/2026 at 23:00, 1 hour 35 minutes ago BIOPHYTIS CHANGES ITS FINANCING AGREEMENT WITH HEXAGON CAPITAL FUND TO ENSURE ITS €2 MILLION FACILITY IS RENEWABLE
Published on 05/27/2026 at 20:28, 4 hours 7 minutes ago Combined Shareholders’ Meeting of May 27, 2026
Published on 05/27/2026 at 17:45, 6 hours 50 minutes ago Imerys-05-2026-communique-capital-droits-de-vote-au-30-avril-2026